You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dinutuximab

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Neuroblastoma Trial in Los Angeles (Dinutuximab with Chemotherapy)

Not yet recruiting
  • Neuroblastoma
  • Dinutuximab with Chemotherapy
  • Los Angeles, California
    Childrens Hospital Los Angeles
Jun 13, 2022

High-risk Neuroblastoma Trial in China (Dinutuximab Beta, 13 cis retinoic acid)

Active, not recruiting
  • High-risk Neuroblastoma
  • Dinutuximab Beta
  • 13 cis retinoic acid
  • Beijing, Beijing, China
  • +3 more
Dec 7, 2022

Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

Recruiting
  • Leiomyosarcoma
  • Dinutuximab Beta, Zoledronic acid, Interleukin-2
  • Bad Saarow, Germany
  • +1 more
Jun 2, 2022

Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in

Not yet recruiting
  • Neuroblastoma
  • +2 more
  • Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Oct 6, 2022

Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

Recruiting
  • Neuroblastoma
  • 131I-MIBG
  • +4 more
  • Los Angeles, California
  • +11 more
Jan 30, 2023

High-Risk Neuroblastoma Trial in Krakow (Chemoimmunotherapy (Dinutuximab beta in combination with chemo))

Recruiting
  • High-Risk Neuroblastoma
  • Chemoimmunotherapy (Dinutuximab beta in combination with chemotherapy)
  • Krakow, Malopolska, Poland
    University Children Hospital
Mar 8, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Neuroblastoma Trial in Worldwide (Data-collection)

Recruiting
  • Neuroblastoma
  • Data-collection
  • Wien,, Vienna, Austria
  • +13 more
Oct 28, 2022

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Osteosarcoma in Children Trial (Dinutuximab beta)

Not yet recruiting
  • Osteosarcoma in Children
  • Dinutuximab beta
  • (no location specified)
Sep 23, 2022

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

Neuroblastoma Trial in Wien, Greifswald (dinutuximab beta)

Active, not recruiting
  • Neuroblastoma
  • dinutuximab beta
  • Wien, Austria
  • +1 more
Oct 1, 2021

Neuroblastoma Trial in Worldwide (Bevacizumab, Temozolomide, Irinotecan)

Active, not recruiting
  • Neuroblastoma
  • Vienna, Austria
  • +9 more
Feb 14, 2022

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

Active, not recruiting
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma
  • Dinutuximab
  • +4 more
  • Mesa, Arizona
  • +77 more
Aug 17, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

Recruiting
  • High Risk Neuroblastoma
  • +2 more
  • Dinutuximab
  • +4 more
  • Birmingham, Alabama
  • +141 more
Dec 28, 2022

Refractory/Relapse Neuroblastoma, Pediatric Solid Tumors With Lung Metastases Trial in Fukuoka (Biological)

Recruiting
  • Refractory/Relapse Neuroblastoma
  • Pediatric Solid Tumors With Lung Metastases
  • Biological
  • Fukuoka, Japan
    Kyushu University Hospital
Nov 7, 2022

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide

Active, not recruiting
Has Results
  • Localized Resectable Neuroblastoma
  • +5 more
  • Aldesleukin
  • +6 more
  • Birmingham, Alabama
  • +196 more
Dec 30, 2022

High-Risk Neuroblastoma Trial in Worldwide (Vincristine, Carboplatin, Etoposide)

Recruiting
  • High-Risk Neuroblastoma
  • Villejuif, Val De Marne, France
  • +15 more
Sep 17, 2021

Neuroblastoma Trial in United States (Ceritinib, dasatinib, sorafenib)

Recruiting
  • Neuroblastoma
  • Birmingham, Alabama
  • +23 more
Sep 26, 2022

Small Cell Lung Cancer Trial in Worldwide (Dinutuximab, Irinotecan, Topotecan)

Completed
Has Results
  • Small Cell Lung Cancer
  • Dinutuximab
  • +2 more
  • Anchorage, Alaska
  • +225 more
Nov 12, 2020

High Risk Neuroblastoma Trial in United States (biological, other, drug)

Completed
Has Results
  • High Risk Neuroblastoma
  • Aldesleukin
  • +4 more
  • Loma Linda, California
  • +31 more
Jul 30, 2021